Her scientific interests lie mostly in Immunology, Regulatory B cells, B cell, Immune system and Interleukin 10. Her work on Cytotoxic T cell expands to the thematically related Immunology. Her biological study spans a wide range of topics, including Inflammation, Antigen, Molecular biology, Autoimmunity and FOXP3.
Her B cell study integrates concerns from other disciplines, such as Immune tolerance and CD40. Claudia Mauri undertakes interdisciplinary study in the fields of Immune system and CD38 through her research. Her study explores the link between Interleukin 10 and topics such as Antibody that cross with problems in Regulatory T cell differentiation, Delayed hypersensitivity, Spleen, Systemic lupus erythematosus and Proinflammatory cytokine.
Claudia Mauri focuses on Immunology, Regulatory B cells, Immune system, Interleukin 10 and Autoimmunity. Her study ties her expertise on Disease together with the subject of Immunology. Her studies in Regulatory B cells integrate themes in fields like Inflammation, CD40 and CD19.
Her Immune system research is multidisciplinary, incorporating perspectives in Gut flora, Antibody and CD80. Her research in Interleukin 10 focuses on subjects like Cellular differentiation, which are connected to Cell. Her research investigates the connection between Autoimmunity and topics such as CTLA-4 that intersect with problems in ZAP70, IL-2 receptor and Acquired immune system.
Claudia Mauri mainly focuses on Immunology, Regulatory B cells, Interleukin 10, Immune system and Disease. Immunology is frequently linked to Inflammatory bowel disease in her study. Her research integrates issues of Computational biology and Cell biology in her study of Regulatory B cells.
Claudia Mauri has researched Interleukin 10 in several fields, including CD19 and CD40. The study incorporates disciplines such as Healthy individuals, Phenotype, Immune homeostasis, Physiology and Immunotherapy in addition to Disease. Her Autoimmunity study combines topics from a wide range of disciplines, such as Autoimmune disease, Flow cytometry and Gut flora.
Regulatory B cells, Immunology, Interleukin 10, B cell and Immune system are her primary areas of study. Regulatory B cells is closely attributed to Cell biology in her study. Claudia Mauri performs integrative study on Immunology and CD38.
In her research on the topic of Interleukin 10, Transcriptional regulation, Chromatin, Cellular differentiation and CD40 is strongly related with CD19. As part of one scientific family, Claudia Mauri deals mainly with the area of B cell, narrowing it down to issues related to the Aryl hydrocarbon receptor, and often Cancer research, Arthritis and Germinal center. Her work carried out in the field of Immune system brings together such families of science as Disease and Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Michael R. Ehrenstein;Jamie G. Evans;Animesh Singh;Samantha Moore.
Journal of Experimental Medicine (2004)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair;Lina Yassin Noreña;Fabian Flores-Borja;David J. Rawlings.
Immune Regulatory Function of B Cells
Claudia Mauri;Anneleen Bosma.
Annual Review of Immunology (2012)
Prevention of Arthritis by Interleukin 10–producing B Cells
Claudia Mauri;David Gray;Naseem Mushtaq;Marco Londei.
Journal of Experimental Medicine (2003)
Regulatory B Cells: Origin, Phenotype, and Function
Elizabeth C. Rosser;Claudia Mauri.
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
Jamie G. Evans;Karina A. Chavez-Rueda;Ayad Eddaoudi;Almut Meyer-Bahlburg.
Journal of Immunology (2007)
Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.
Suchita Nadkarni;Claudia Mauri;Michael R. Ehrenstein.
Journal of Experimental Medicine (2007)
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Fabian Flores-Borja;Anneleen Bosma;Dorothy Ng;Venkat Reddy.
Science Translational Medicine (2013)
Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
Natalie A. Carter;Rita Vasconcellos;Elizabeth C. Rosser;Calogero Tulone.
Journal of Immunology (2011)
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.
Claudia Monaco;Evangelos Andreakos;Serafim Kiriakidis;Claudia Mauri.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Journal of Retailing and Consumer Services
(Impact Factor: 4.219)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: